Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins.
Adaptor Proteins, Signal Transducing
/ genetics
Animals
Apoptosis Regulatory Proteins
/ genetics
Cell Line, Tumor
Coinfection
/ immunology
Host Microbial Interactions
Humans
Influenza A virus
/ physiology
Influenza, Human
/ immunology
Intracellular Signaling Peptides and Proteins
/ genetics
Israel
Lung
/ virology
Mice
Mice, Inbred BALB C
Microbial Interactions
Morbidity
RNA-Binding Proteins
/ genetics
Respiratory Syncytial Virus Infections
/ immunology
Respiratory Syncytial Virus, Human
Retrospective Studies
Seasons
Up-Regulation
IFITs
Influenza A
RSV
double infection
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
16 10 2020
16 10 2020
Historique:
received:
31
08
2020
revised:
09
10
2020
accepted:
12
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
27
2
2021
Statut:
epublish
Résumé
Influenza viruses and respiratory syncytial virus (RSV) are respiratory viruses that primarily circulate worldwide during the autumn and winter seasons. Seasonal surveillance has shown that RSV infection generally precedes influenza. However, in the last four winter seasons (2016-2020) an overlap of the morbidity peaks of both viruses was observed in Israel, and was paralleled by significantly lower RSV infection rates. To investigate whether the influenza A virus inhibits RSV, human cervical carcinoma (HEp2) cells or mice were co-infected with influenza A and RSV. Influenza A inhibited RSV growth, both in vitro and in vivo. Mass spectrometry analysis of mouse lungs infected with influenza A identified a two-wave pattern of protein expression upregulation, which included members of the interferon-induced protein with the tetratricopeptide (IFITs) family. Interestingly, in the second wave, influenza A viruses were no longer detectable in mouse lungs. In addition, knockdown and overexpression of IFITs in HEp2 cells affected RSV multiplicity. In conclusion, influenza A infection inhibits RSV infectivity via upregulation of IFIT proteins in a two-wave modality. Understanding the immune system involvement in the interaction between influenza A and RSV viruses will contribute to the development of future treatment strategies against these viruses.
Identifiants
pubmed: 33081322
pii: v12101171
doi: 10.3390/v12101171
pmc: PMC7589235
pii:
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Apoptosis Regulatory Proteins
0
Ifit1 protein, mouse
0
Ifit2 protein, mouse
0
Ifit3 protein, mouse
0
Intracellular Signaling Peptides and Proteins
0
RNA-Binding Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Expert Rev Vaccines. 2018 Nov;17(11):977-987
pubmed: 30365908
Nat Immunol. 2011 Jun 05;12(7):624-30
pubmed: 21642987
Influenza Other Respir Viruses. 2014 Jul;8(4):422-30
pubmed: 24698156
Ital J Pediatr. 2015 Apr 18;41:33
pubmed: 25903455
Am J Emerg Med. 2017 Mar;35(3):495-498
pubmed: 28012809
Cell Host Microbe. 2010 Jun 25;7(6):440-51
pubmed: 20542248
J Gen Virol. 2013 Jan;94(Pt 1):59-68
pubmed: 23052390
PLoS One. 2012;7(4):e34750
pubmed: 22496855
J Immunol. 2007 Aug 1;179(3):1438-48
pubmed: 17641009
mBio. 2019 Aug 27;10(4):
pubmed: 31455651
J Exp Med. 2000 Nov 6;192(9):1317-26
pubmed: 11067880
PLoS One. 2014 Mar 03;9(3):e90515
pubmed: 24594694
BMC Infect Dis. 2018 Dec 7;18(1):637
pubmed: 30526505
Heliyon. 2019 Jan 03;5(1):e01094
pubmed: 30623128
Nucleic Acids Res. 2014 Mar;42(5):3228-45
pubmed: 24371270
Mucosal Immunol. 2010 Jan;3(1):69-80
pubmed: 19710636
Epidemiol Infect. 2016 Sep;144(12):2621-32
pubmed: 27165946
Euro Surveill. 2018 Feb;23(7):
pubmed: 29471622
PLoS Pathog. 2013;9(10):e1003663
pubmed: 24098121
J Virol. 2016 Sep 29;90(20):9446-56
pubmed: 27512068
Influenza Other Respir Viruses. 2020 Jan;14(1):77-91
pubmed: 31568678
Elife. 2016 May 31;5:
pubmed: 27240734
J Leukoc Biol. 2007 May;81(5):1224-35
pubmed: 17311932
J Hepatol. 2014 Nov;61(1 Suppl):S14-25
pubmed: 25443342
J Immunol. 2007 Mar 1;178(5):2755-62
pubmed: 17312118
Nat Rev Microbiol. 2014 Apr;12(4):252-62
pubmed: 24590244
Sci Rep. 2012;2:515
pubmed: 22808421
Science. 2006 Apr 14;312(5771):212-7
pubmed: 16614208
Int J Biol Sci. 2013;9(2):200-8
pubmed: 23459883
Eur J Biochem. 1994 Sep 15;224(3):877-83
pubmed: 7925411
Immunity. 2018 Mar 20;48(3):487-499.e5
pubmed: 29525521
Front Immunol. 2018 Jul 03;9:1521
pubmed: 30018617
Expert Rev Respir Med. 2018 Nov;12(11):931-939
pubmed: 30241450
Arch Intern Med. 2002 Jun 10;162(11):1229-36
pubmed: 12038940
Med Clin (Barc). 2018 Sep 14;151(5):171-190
pubmed: 30037695
J Virol. 2015 Mar;89(5):2462-8
pubmed: 25428874
J Virol. 2016 Jun 10;90(13):5965-5977
pubmed: 27099320
J Gen Virol. 2018 Nov;99(11):1463-1477
pubmed: 30234477
J Virol. 2016 Nov 28;90(24):11145-11156
pubmed: 27707917
Sci Rep. 2018 Mar 14;8(1):4491
pubmed: 29540836